RARE vs VSTD · rev $560.2M vs rev $12.8M
Ultragenyx (RARE) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
RARE currently screens at market cap $2.79B. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the RARE and VSTD stock pages for the full models.
Not investment advice.